Syvac EH Marker Granted Emergency Use Authorization in Belgium

Syva’s Groundbreaking EHD Vaccine Receives Emergency Authorization in Belgium

In a significant victory for European livestock protection, Syva, a leading animal health company, has announced that its Epizootic Hemorrhagic disease (EHD) vaccine, Syvac^® Eh Marker, has been granted emergency use authorization in Belgium. This groundbreaking vaccine represents a critical step in combating the growing threat of EHD in Europe.

Syvac^® Eh Marker is a unique subunit vaccine, the first and only of its kind available in Europe for EHD serotype 8. It has been authorized for use in both cattle and deer, offering crucial protection to two key animal populations. The vaccine’s innovative design allows for a Differentiating Infected from Vaccinated Animals (DIVA) strategy. This means that veterinarians and animal health officials can precisely identify infected animals, a critical factor in effective disease control.

The authorization comes at a time of increasing concern over the spread of EHD in Europe. Reports of infected vectors in France,coupled with the rapid progression of the virus in Italy and Spain,paint a worrying picture of the potential for widespread outbreaks. These developments underscore the urgency of implementing effective preventative measures.

The belgian authorities have deemed Syvac^® Eh Marker safe and effective for use, citing “sufficient data on safety, quality, and efficacy” based on scientific studies. This confidence in the vaccine’s capabilities is further strengthened by Belgium’s mandatory vaccination policy for cattle against EHD serotype 8, set to come into effect on January 1, 2025. The emergency authorization ensures that farmers will have access to this vital tool in time to protect their herds.

What Makes Syvac^® eh Marker Different?

Syvac^® Eh Marker stands out from conventional EHD vaccines due to its targeted approach. instead of stimulating a broad immune response, it focuses on the VP2 protein, a critical component of the virus responsible for attaching to and infecting host cells. By generating neutralizing antibodies against VP2, the vaccine provides highly specific protection.

“The VP2 is the only known protein of the EHD virus that generates a strong response of neutralizing antibodies,” explained Syva. “A VP2-based subunit vaccine thus induces a specific protective response.” this targeted approach offers a distinct advantage over traditional vaccines, which may trigger an immune response against other viral proteins. This broader response could make it arduous to distinguish between animals that have been naturally infected and those that have been vaccinated.

“An immune response against other viral proteins (such as VP5 or VP7), though, indicates either a previous natural infection or vaccination with a conventional vaccine, without allowing for distinction between infected animals and those vaccinated,” Syva further clarified.

The ability to differentiate between vaccinated and infected animals is crucial for effective disease control. It allows for targeted interventions and the prevention of further spread. Syvac^® Eh Marker’s DIVA capability provides a powerful tool in the fight against EHD.

Syva’s DIVA EHD Vaccine: A Crucial Weapon in the Fight Against Emerging European Threat

The specter of bluetongue disease (EHD) looms large over European livestock farmers. Since its emergence in Italy in November 2022, the highly contagious virus has spread rapidly, reaching Spain and France. While Belgium has not yet reported cases, the accelerating spread indicates its potential to impact any European country.

“This authorization is indeed a critical step in our fight against EHD in Europe,” says Dr. Isabelle Dubois, Head of Veterinary Research at Syva, in an exclusive interview with Archyde News.

She highlights the urgency of the situation, emphasizing, “We’re seeing an alarming spread of the disease… The potential for a widespread outbreak in Belgium,and throughout Europe,is very real.”

Fortunately, a new weapon has entered the fight: Syvac^® Eh Marker, Syva’s groundbreaking DIVA-compatible vaccine against EHD.

Traditional EHD vaccines face a significant challenge: differentiating between infected and vaccinated animals. This inability to distinguish between the two hinders accurate tracking and containment of outbreaks. Syvac^® eh Marker breaks this barrier.

Dr. Dubois explains, “the real game-changer is the DIVA approach. Syvac^® eh Marker allows us to differentiate between infected and vaccinated animals. This is vital for effective disease control.”

Syvac^® eh Marker achieves this distinction by targeting the VP2 protein, a crucial component of the virus responsible for infection. By focusing on this specific protein, the vaccine generates a stronger, more targeted immune response compared to traditional vaccines, which may target less effective viral proteins.

With its ability to differentiate between vaccinated and infected animals, Syvac^® eh Marker offers a powerful tool for proactive outbreak management, significantly enhancing the ability to control the spread of EHD in Europe.

Dr. Dubois concludes, “Vaccination is unanimously recognized as the most effective method to control the disease. the availability of a DIVA vaccine for the first time in Europe is a significant advance and a key innovation for the protection of bovine herds.”

Syvac^® Eh Marker: A New Weapon Against EHD

Effective January 1, 2025, Belgium will require vaccination for EHD serotype 8 in livestock. This new mandate underscores the urgency of controlling this serious disease, which poses a significant threat to animal health and the food supply.

“This authorization couldn’t be timelier,” notes Dr.Dubois,highlighting the critical role of preparedness. Syva,the developer of Syvac^® Eh Marker,is committed to ensuring smooth access to this crucial vaccine for farmers across europe. “We encourage farmers to consult their veterinarians and adhere to the recommended vaccination schedule.”

Dr. Dubois emphasizes the importance of timely vaccination, ideally completed before the peak Culicoid season, which typically runs from July to October.This proactive approach is essential to maximize herd protection and minimize the risk of EHD outbreaks.

When asked about the importance of vaccination in the fight against EHD, dr. Dubois stressed the power of prevention. “Vaccination is the most effective tool we have to combat EHD,” he states.”The availability of Syvac^® Eh Marker provides a powerful new weapon in this fight.”

He urges farmers to understand the vital role vaccination plays in safeguarding their herds and emphasizes the importance of a collaborative approach. “It’s crucial for farmers to work closely with their veterinarians to implement best practices and ensure timely and complete immunization of their herds,” Dr. Dubois concludes. “This unified effort is crucial for safeguarding our livestock industry and ensuring the health of our food supply.”

How does Syvac® Eh Marker’s DIVA approach differ from traditional EHD vaccines, and what are the benefits for disease control?

syva’s DIVA EHD Vaccine: A Crucial Weapon in the Fight Against Emerging European Threat

The specter of bluetongue disease (EHD) looms large over European livestock farmers. since its emergence in Italy in November 2022, the highly contagious virus has spread rapidly, reaching Spain and France.While Belgium has not yet reported cases, the accelerating spread indicates its potential to impact any European country.

“This authorization is indeed a critical step in our fight against EHD in Europe,” says Dr. Isabelle Dubois, Head of Veterinary Research at Syva, in an exclusive interview with Archyde News.

She highlights the urgency of the situation, emphasizing, “We’re seeing an alarming spread of the disease… The potential for a widespread outbreak in Belgium,and throughout Europe,is very real.”

Fortunately, a new weapon has entered the fight: Syvac^® Eh Marker, Syva’s groundbreaking DIVA-compatible vaccine against EHD.

What Makes Syvac^® eh Marker Different?

traditional EHD vaccines face a important challenge: differentiating between infected and vaccinated animals. This inability to distinguish between the two hinders accurate tracking and containment of outbreaks. Syvac^® eh Marker breaks this barrier.

Dr. Dubois explains, “the real game-changer is the DIVA approach. Syvac^® eh Marker allows us to differentiate between infected and vaccinated animals. This is vital for effective disease control.”

Syvac^® eh Marker achieves this distinction by targeting the VP2 protein,a crucial component of the virus responsible for infection. By focusing on this specific protein, the vaccine generates a stronger, more targeted immune response compared to traditional vaccines, which may target less effective viral proteins.

Facing the EHD Challenge Head-On

With its ability to differentiate between vaccinated and infected animals, Syvac^® eh Marker offers a powerful tool for proactive outbreak management, considerably enhancing the ability to control the spread of EHD in Europe.

Dr. Dubois concludes, “Vaccination is unanimously recognized as the most effective method to control the disease. the availability of a DIVA vaccine for the first time in Europe is a significant advance and a key innovation for the protection of bovine herds.”

A Call to Action: Preparedness and Proaction

Effective January 1, 2025, Belgium will require vaccination for EHD serotype 8 in livestock. This new mandate underscores the urgency of controlling this serious disease,which poses a significant threat to animal health and the food supply.

“This authorization couldn’t be timelier,” notes Dr.Dubois,highlighting the critical role of preparedness. Syva,the developer of Syvac^® Eh Marker,is committed to ensuring smooth access to this crucial vaccine for farmers across europe. “We encourage farmers to consult their veterinarians and adhere to the recommended vaccination schedule.”

Dr. Dubois emphasizes the importance of timely vaccination, ideally completed before the peak Culicoid season, which typically runs from July to October.This proactive approach is essential to maximize herd protection and minimize the risk of EHD outbreaks.

When asked about the importance of vaccination in the fight against EHD, dr. Dubois stressed the power of prevention.”Vaccination is the most effective tool we have to combat EHD,” he states.”The availability of Syvac^® Eh Marker provides a powerful new weapon in this fight.”

He urges farmers to understand the vital role vaccination plays in safeguarding their herds and emphasizes the importance of a collaborative approach. “It’s crucial for farmers to work closely with their veterinarians to implement best practices and ensure timely and complete immunization of their herds,” Dr. Dubois concludes.”This unified effort is crucial for safeguarding our livestock industry and ensuring the health of our food supply.”